Dr. Farha Nasim, Dr. Surupa Dutta, Prof.(Dr.) Manoj Kumar Singh, Prof.(Dr.) Abhijit Chakraborty, Dr. Debarghya Pal, Dr. Debarshi Jana


Periodontal disease involves complex interplay between the pathogens and the host. Probiotic therapy, being natural with no adverse-effects,
carries great potential in improving the clinical signs of periodontal disease by reducing the bacterial load and modulating host immune response.
Here an approach has been made to highlight the efficacy of probiotics for treating periodontal disease based on the existing status of knowledge.


Probiotics, Periodontal disease, Bacterio-therapy

Full Text:



Chickanna R, Prabhuji M, Nagarjuna M. Host-bacterial interplay in periodontal disease. J Int Clin Dent Res Organ 2015;7:44-50.

Socransky S, Haffajee A. The Bacterial Etiology of Destructive Periodontal Disease: Current Concepts. J Periodontol 1992;63(4 Suppl):322-31.

Cobb CM. Clinical significance of non-surgical periodontal therapy: an evidence-based perspective of scaling and root planing. J Clin Periodontol. 2002;2(29 Suppl):6-16.

Wang L, Chen Hu, Shao. The antimicrobial activity ofnanoparticles: present situation and prospects for the future. Int J Nanomedicine 2017;12:1227–49.

Roberts FA, Darveau RP. Beneficial bacteria of the periodontium. Periodontol 2000 2002;30:40-50.

Food and Agriculture Organization and World Health Organization Expert Consultation. Evaluation of health and nutritional properties of powder milk and live lactic acid bacteria. Córdoba, Argentina: Food and Agriculture Organization of the United Nations and World Health Organization;2001.

Chatterjee A, Bhattacharya H, Kandwal A. Probiotics in periodontal health and disease. J Indian Soc Periodontol 2011;15:23-8.

Kollath W (1953) The increase of the diseases of civilization and their prevention]. Munch Med Wochenschr 95: 1260-1262. UMC229175.pdf

Oelschlaeger TA. Mechanisms of probiotic actions-A review. IntJ Med Microbiol 2010;300:57–62.

Elli M, Zink R, Rytz A, Reniero R,Morelli L. Iron requirement of Lactobacillus spp. in completely chemically defined growth media. J Appl Microbiol 2000;88:695–703.

Stamatova I, Meurman JH. Probiotics and periodontal disease. Periodontol 2000 2009;51:141–51.

Jain P, Sharma P. Probiotics and Their Efficacy in Improving Oral Health: A Review J App Pharm Sci. 2012;2:151-63.

Bermudez-Brito M, Plaza-Díaz J, Muñoz-Quezada S, Gómez-Llorente C, Gil A. Probiotic Mechanisms of Action. Annals of Nutrition and Metabolism 2012;61:160–74.

Kang MS, Kim BG, Chung J, Lee HC, Oh JS. Inhibitory effect of Weissella cibaria isolates on the production of volatile sulphur compounds. J Clin Periodontol 2006;33:226-32.

Cheikhyoussef A, Pogori N, Chen W, Zhang H. Antimicrobial proteinaceous compounds obtained from bifidobacteria: from production to their application. Int J Food Microbiol 2008;125:215–22.

Grangette C, Nutten S, Palumbo E, Morath S, Hermann C, Dewulf J,et al. Enhanced anti-inflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified Teichoic acids. Proc Natl Acad Sci USA 2005;102:10321-6.

Gogineni VK, Morrow LE, Malesker MA. Probiotics: Mechanisms of action and clinical applications. J Prob Health 2013;1:101.

Mennigen R, Nolte K, Rijcken E, Utech M, Loeffler B, Senninger N,et al. Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol 2009;296:1140-9.

Riccia DN, Bizzini F, Perilli MG, Polimeni A, Trinchieri V, Amicosante G,et al. Anti‑inflammatory effects of L. brevis (DC2) on periodontal disease. Oral Dis 2007;13:376‑85.

Twetman S, Derawi B, Keller MK, Ekstrand K, Lindberg TY,Stecksén-Blicks C: Short-term effect of chewing gums containing probiotic Lactobacillus reuteri on the levels of inflammatory mediators in gingival crevicular fluid. Acta Odontologica Scandinavica 2009;67:19-24.

Takeda K, Suzuki T, Shimada SI, Shida K, Nanno M, Okumura K. Interleukin‑12 is involved in the enhancement of human natural killer cell activity by Lactobacillus casei Shirota. Clin Exp Immunol 2006;146:109‑15.

Pozharitskaia MM, Morozova LV, Melnichuk GM, Melnichuk SS. The use of the new bacterial bio-preparation Acilact in the combined treatment of periodontitis. Stomatologiia (Mosk) 1994;73:17-20.

Grudianov AI, Dmitrieva NA, Fomenko EV. Use of probiotics Bifidumbacterin and Acilact in tablets in therapy of periodontal inflammations. Stomatologiia (Mosk) 2002;81:39-43.

Ishikawa H, Aiba Y, Nakanishi M, Oh-Hashi Y, Koga Y. Suppression of periodontal pathogenic bacteria in the saliva of human by the administration of Lactobacillus salivarius TI2711. J Jap Soc Periodontol 2003;45:105–12.

Narva M, Halleen J, Väänänen K, Korpela R. Effects of Lactobacillus helveticus fermented milk on bone cells in vitro. Life Sci. 2004;75:1727–34.

Krasse P, Carlsson B, Dahl C. Decreased gum bleeding and reduced gingivitis by the probiotic Lactobacillus reuteri. Swed Dent J. 2006;30:55–60.

Shimauchi H, Mayanagi G, Nakaya S, Minamibuchi M, Ito Y, Yamaki K,et al. Improvement of periodontal condition by probiotics with lactobacillus salivarius WB 21: A randomized, double- blind, placebo controlled study. J Clin Periodontol 2008;35:897-905.

Vivekananda MR, Vandana KL, Bhat KG. Effect of the probiotic Lactobacilli reuteri (Prodentis) in the management of periodontal disease: A preliminary randomized clinical trial. J Oral Microbiol 2010;2:5344.

Shah MP, Gujjari SK, Chandrasekhar VS. Evaluation of the effect of probiotic (inersan®) alone, combination of probiotic with doxycycline and doxycycline alone on aggressive periodontitis – A clinical and microbiological study. J Clin Diagn Res 2013;7:595-600.

Volozhin AI, Il‘in VK, Maksimovskii IuM, Sidorenko AB, Istranov LP, Tsarev VN,et al. Development and use of periodontal dressing of collagen and Lactobacillus casei 37 cell suspension in combined treatment of periodontal disease of inflammatory origin (a microbiological study). Stomatologiia (Mosk) 2004;83:6–8.

Zahradnik RT, Magnusson I, Walker C, McDonell E, Hillman CH, Hillman JD. Preliminary assessment of safety and effectiveness in humans of ProBiora3 ™, a probiotic mouthwash. J Appl Microbiol 2009;107:682–90.

Gibson GR, Roberfroid MB. Dietary Modulation of the Human Colonic Microbiota: introducing the concept of prebiotics. J Nutr 1995;125:1401–12.

Cannon JP, Lee TA, Bolanos JT, Danziger LH. Pathogenic relevance of Lactobacillus. a retrospective review of over 200 cases. Eur J Clin Microbiol Infect Dis 2005;24:31-40.


  • There are currently no refbacks.